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Spin-Labeling Magnetic Resonance Imaging Detects Increased
Myocardial Blood Flow After Endothelial Cell Transplantation in the
Infarcted Heart
Abstract
Background
We quantified absolute myocardial blood flow (MBF) using a spin-labeling MRI (SL-MRI) method after
transplantation of endothelial cells (ECs) into the infarcted heart. Our aims were to study the temporal
changes in MBF in response to EC transplantation and to compare regional MBF with contractile function
(wall motion) and microvascular density.
Methods and Result
We first validated the SL-MRI method with the standard microsphere technique in normal rats. We then
induced myocardial infarction in athymic rats and injected 5 million ECs (human umbilical vein endothelial
cells) suspended in Matrigel or Matrigel alone (vehicle) along the border of the blanched infarcted area. At 2
weeks after myocardial infarction, MBF averaged over the entire slice (P=0.038) and in the infarcted region
(P=0.0086) was significantly higher in EC versus vehicle group; the greater MBF was accompanied by an
increase of microvasculature density in the infarcted region (P=0.0105 versus vehicle). At 4 weeks after
myocardial infarction, MBF in the remote region was significantly elevated in EC-treated hearts (P=0.0277);
this was accompanied by increased wall motion in this region assessed by circumferential strains (P=0.0075).
Intraclass correlation coefficients and Bland-Altman plot revealed a good reproducibility of the SL-MRI
method.
Conclusion
MBF in free-breathing rats measured by SL-MRI is validated by the standard color microsphere technique.
SL-MRI allows quantification of temporal changes of regional MBF in response to EC treatment. The proof-
of-principle study indicates that MBF is a unique and sensitive index to evaluate EC-mediated therapy for the
infarcted heart.
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Abstract
Background—We quantified absolute myocardial blood flow (MBF) using a spin labeling
magnetic resonance imaging (SL-MRI) method after transplantation of endothelial cells (ECs) into
the infarcted heart. Our aims were to study the temporal changes in MBF in response to EC
transplantation, and to compare regional MBF with contractile function (wall motion) and
microvascular density.
Methods and Results—We first validated the SL-MRI method with the standard microsphere
technique in normal rats. We then induced myocardial infarction (MI) in athymic rats and injected
5-million ECs (human umbilical vein endothelial cells) suspended in Matrigel or Matrigel alone
(vehicle) along the border of the blanched infarcted area. At 2-weeks post-MI, MBF averaged over
the entire slice (p = 0.038) and in the infarcted region (p = 0.0086) was significantly higher in EC
vs. vehicle group; the greater MBF was accompanied by an increase of microvasculature density
in the infarcted region (p = 0.0105 vs. vehicle). At 4-weeks post-MI, MBF in the remote region
was significantly elevated in EC-treated hearts (p = 0.0277); this was accompanied by increased
wall motion in this region assessed by circumferential strains. Intraclass correlation coefficients
and Bland-Altman plot revealed a good reproducibility of the SL-MRI method.
Conclusions—Myocardial blood flow in free-breathing rats measured by SL-MRI is validated
by the standard color microsphere technique. SL-MRI allows quantification of temporal changes
of regional MBF in response to EC treatment. The proof-of-principle study indicates that MBF is a
unique and sensitive index to evaluate EC-mediated therapy for the infarcted heart.
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Quantification of absolute myocardial blood flow (MBF, in units of mL per minute per gram
of tissue) is important when evaluating stem cell mediated treatment of myocardial
infarction (MI). First, the ability of local blood supply to match metabolic demand of the
tissue will affect the survival of grafted cells. Second, new vasculature formed by either
transplanted cells or host cells will improve perfusion, which then facilitates graft survival
and expansion. Since an increase in capillary density does not necessarily lead to an increase
of blood flow in vivo 1, a non-invasive quantification of MBF is desirable, and a measurable
increase in MBF can be a specific index to determine the success of therapeutic
angiogenesis or vasculogenesis in the infarcted heart.
In the REPAIR-AMI clinical trial 2, bone marrow-derived progenitor cells (BMCs) were
infused in patients with reperfused acute MI. By measuring blood flow using an
intracoronary Doppler probe, the investigators found that the coronary flow reserve (CFR,
defined as the ratio of the maximal to the resting coronary blood flow) of infarct-related
arteries recovered to a normal level in BMC-treated patients but not in placebo controls.
CFR thus provided direct evidence that BMCs restored microvascular function of infarct-
related arteries. Microvascular function, quantified by MBF, could be an important predictor
of global functional recovery which was achieved in some BMC trials 3 but not in others 4,5.
While BMCs are a mixture of various types of cells, fully differentiated endothelial cells
(ECs) 6 or endothelial progenitor cells (EPCs) 7,8 represent a more purified cell population
and have been suggested to form new vasculature, preserve LV function and inhibit
apoptosis in the infarcted heart. However, mechanisms underlying the salutary effects of
these cells are not well understood: specifically, whether or not neovascularization leads to
improved regional MBF has not been studied extensively.
To evaluate EC- or EPC-mediated vascular repair over time and to be able to translate it to
the clinic, non-invasive imaging based methods for MBF estimation are desirable. At
present, positron emission tomography (PET) is the clinical standard for MBF
measurement 9. First-pass contrast-enhanced MRI can be used to quantify MBF only after
extensive modeling of the kinetic data 10. In contrast, spin labeling-based magnetic
resonance imaging (SL-MRI) utilizes endogenous water molecules, eliminating the need to
inject any exogenous tracers. First implemented on the heart by Belle et al on the rat in
vivo 11,12, this technique has proven effective for mapping MBF in rapidly beating rodent
hearts to study cardiovascular diseases in such models 13–17.
In this study, first, we validated the SL-MRI method with a standard microsphere technique;
second, we utilized SL-MRI to detect changes of MBF over time in the infarcted, border and
remote regions in response to EC transplantation, and demonstrated that the improved MBF
is corroborated with increased wall motion and microvascular density in the corresponding
regions.
Methods
1. Experimental design and study groups
All animal procedures were approved by the local Institutional Animal Care and Use
Committee. This study has two aims. Aim-1 is to validate the SL-MRI based MBF
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measurement, while Aim-2 is to assess the utility of SL-MRI for detecting MBF changes
mediated by EC transplantation in an MI model.
For Aim-1, a total of 18 rats were used; 5 rats completed the study while 13 died during
procedures (Section 3). For Aim-2, ECs in the form of human umbilical vein endothelial
cells (HUVECs, ATCC, Manassas, VA) were expanded (≤ 6–10 passages) and suspended in
growth factor-reduced Matrigel (Collaborative Biomedical, Bedford, MA). MI was induced
in male athymic nu/nu rats (6–8 weeks old, Frederick Cancer Center, Frederick, MD) by
permanent ligation of the left anterior descending coronary artery 18. During the same
surgical session, 5-million ECs in 100 μl Matrigel, or Matrigel alone (vehicle) were injected
in one spot in the border close to the blanched area. Initial infarct size (as a percentage of
LV myocardial volume) was assessed at 1 day post-MI using late gadolinium enhancement
(LGE), and rats having infarct size outside the range of [10%, 30%] were excluded as we
described previously.18,19 A total of 51 rats (26 were assigned to EC and 25 to Vehicle
group) were used in Aim-2; 22 died from surgery and 7 were excluded at Day-1 due to
unqualified infarct size; remaining 22 rats (n = 12 in EC and n = 10 in Vehicle group)
proceeded to studies at 2-weeks and 4 rats in EC and 3 in Vehicle group were euthanized for
microvasculature density (MVD) analysis; the remaining 15 animals were imaged and
euthanized at 4-weeks. As the result of instrument downtime, there are missing MBF data
from unscanned rats at 1-day and 2-weeks, whereas all rats were scanned at 4-weeks; the
number of rats scanned at each time point was specified in figures.
2. SL-MRI based MBF quantification
MR experiments were performed on a 4.7T horizontal bore magnet interfaced to a Varian
DirectDrive™ console. A combination of a transverse electro-magnetic (TEM) volume
transmit coil and surface receive coil (InsightMRI, Worcester, MA) 18,19 was interfaced to a
12 cm gradient insert with maximum strength of 25G/cm. The rat was maintained under
anesthesia by 1.5% (unless indicated otherwise) isoflurane mixed with oxygen at a flow rate
of 1L/min via a nose cone. ECG and respiration were monitored (SA Instruments, Stony
Brook, NY) and core temperature was maintained at 36.5 ± 0.2°C by warm air. A gel
phantom (with relaxation time, T1, slightly longer than normal myocardium) was fixed on
the animal holder.
Data acquisition—We modified the SL-MRI protocol by Kober et al 20, in which ECG-
and respiration-gated gradient echo technique was utilized to achieve high spatial resolution
perfusion maps in free-breathing animals. Instead of referencing the phantom with a known
T1 to derive tissue T1 values, our protocol directly calculates T1 from a series of inversion
recovery images using a least-square fitting algorithm 21,22. Consequently, the mean
perfusion value of the phantom being close to 0 was used as a criterion to evaluate the
quality of raw data and T1 fitting.
MBF was measured from a 3-mm short axis slice at mid left ventricle. To map T1
corresponding to non-slice-selective and slice-selective inversion of the magnetization, a
modified TOMROP sequence 21,23 was used, which consists of an inversion pulse (followed
by crusher gradients) and a gradient echo module that samples the same phase-encoding line
multiple times along the magnetization recovery. A hyperbolic secant adiabatic pulse 24
lasting 6–7 ms (permitted by RF coil power limit) was used for the inversion. The slice
thickness of the inversion pulse was set to a large value (3×105 mm) in the case of global
inversion, and to 2.5 times of the imaging slice thickness in the case of slice-selective
inversion. The ratio of 2.5 was to compensate the imperfect matching of the inversion and
excitation pulse profiles, and was determined using the agarose gel phantom (i.e., under the
no-flow condition) by stepwise increasing the ratio of inversion to excitation pulse slice
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width as 1, 1.5, 2, 2.5, 3, 3.5 and identifying the smallest inversion pulse slice width that can
achieve the “zero” flow results in the phantom.
Immediately after the inversion pulse and under ECG-gating, a series of images were
acquired for at least 7-sec followed by a 4-sec delay to ensure that the spins in myocardium
were recovered to > 99% of the equilibrium magnetization before the next inversion pulse.
The respiratory waveform and k-space acquisitions were simultaneously recorded (SA
Instrument, Stony Brook, NY) for retrospective elimination of images acquired outside the
quiescent phase of expiration. The following parameters were used: field of view (FOV) =
35 × 35 mm2, acquisition matrix = 192 × 80, TE = 2.19 ms, bandwidth = 96 kHz, inversion
time spacing = 2 heart beats, Gaussian excitation pulse of 800-μs and 10° flip angle; each
pair of T1 measurements took about 25 min; 2 signal averages.
Data processing—A three-parameter fitting algorithm 21,22 was used to calculate pixel-
wise T1 values under non-slice-selective and slice-selective inversion, designated as T1ns
and T1ss, respectively. The pixel-wise blood flow was quantified using the formula
below 11:
[1]
where  is the tissue-blood partition coefficient of water
and was set to 0.83 mL/g for rat myocardium. T1b is the blood T1 under global inversion
and was set to 1.6-sec at 200 MHz 11. The phantom was included for flow calculation
(Figure 1A), and an MBF measurement was accepted if the phantom had a mean flow value
within ±0.5 mL/min/g; if rejected, the data was reacquired within 2 days of the 2-weeks and
4-weeks time points in the EC study or considered as missing.
3. Validation of SL-MRI based MBF with microsphere method
Before the SL-MRI session, the carotid artery (for direct injection of microspheres into LV)
and femoral artery (for withdrawal of reference blood) were cannulated 25. Placement of the
catheter inside LV was verified by proper length of the inserted catheter and rapid blood
pulsations in the catheter.
Immediately after SL-MRI, 200,000 fluorescent microspheres (FMs) of 15 μm diameter
(Dye-Trak, Triton Technology, San Diego, CA) in 200 μL saline was infused in 10-sec
followed by 500 μL saline flush for 20-sec. Meanwhile, reference blood was withdrawn
through the femoral artery catheter at 330 μL/min via a syringe pump (Harvard Apparatus,
Boston, MA) starting 30-sec before the FM injection and lasting for 180-sec. Upon
completion of blood sampling, the heart was harvested and embedded in 1 % agarose gel.
A fluorescent plate/slide imaging protocol 26 was used to quantify the number of FMs. The
heart was sectioned into ~100 μm thick sections on a vibratom (Leica VT1000S, Leica
Microsystems GmbH, Germany). Sections corresponding to the imaging slice were
determined by their positions relative to the apex and mounted on microscope slides. FMs in
the reference blood were retrieved by membrane filters, which were also mounted on slides.
The slides were then scanned on a fluorescent plate reader (Alpha Innotech, CA). The
number of microspheres in slides was counted by a custom program written in MATLAB
(Mathworks, Natick, MA). MBF was estimated based on the amount of FMs in the tissue
and reference blood as well as thereference blood withdrawal rate25.
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4. Cardiac function post EC transplantation evaluated by MRI
MBF was measured at 1-day, 2- and 4- weeks post-MI, while the infarct size and LVEF 27
was estimated at 1-day and 4-weeks. Regional wall motion was measured at 4-weeks only,
from the same slice position as MBF but with 1.5-mm thickness. The MRI protocol for wall
motion which was detailed previously 19 was updated to a tag spacing of 0.9-mm (ke = 1.11
cycle/mm) and 10 cardiac frames (15-ms per frame). To obtain regional MBF and wall
motion, LV myocardium was segmented into I-B-R, where infarcted (I) region was defined
on the LGE image (at the same position as MBF slice), border region (B) as two 60° sectors
on each side of the infarcted segment, and the remote region (R) encompassed the remaining
myocardium.
5. MVD and incorporation of grafted ECs into vasculature
MVD was estimated at 2- and 4-weeks. Upon euthanasia, a 5-mm thick slab centered at the
mid-ventricle level was embedded in Optimal Cutting Temperature media and cut in short
axis orientation. After trimming off 1-mm top layer, three sections (each 10-μm thick) were
cut at 3 levels with 1-mm spacing. Sections were immunostained using the following
antibodies: 1. rabbit polyclonal anti- von Willebrand Factor (vWF) antibody (Sigma, St.
Louis, MO) and FITC-conjugated goat anti-rabbit secondary antibody, 2. mouse monoclonal
anti-human CD34 antibody (Abcam, Cambridge, MA) and Cy3-conjugated goat anti-mouse
secondary antibody. One section at each level was H&E stained.
To estimate regional MVD, each section was segmented into the I-B-R region under 2X
objective lens: infarcted region was identified on the adjacent H&E section; the border and
remote regions were defined in the same way as on MRI. Then under 10X, at least 6 FOVs
(each covering 1.1-mm2) were captured including 3 in the Remote, 2 in the Border, and 1–3
in the Infarcted region depending on the infarct size. Clustered cells or continuous branching
structures with positive vWF staining were counted as one capillary. To visualize engrafted
ECs, double immunostaining for human CD34 and vWF was performed.
6. Statistical analyses
Data are presented as mean (± standard deviation) in both text and figures. The Bland-
Altman plot and intraclass correlation coefficients (ICC, MedCalc 11.6, Mariakerke,
Belgium) calculated from segmental and sliced-averaged MBF were used to evaluate the
agreement between MRI- and FM-based MBF measurements. The same approaches were
applied to 12 animals (6 in EC and 6 in Vehicle group), each having two serial scans in the
same imaging session at 2-weeks post-MI, for assessing the reproducibility of the SL-MRI
method. To assess the treatment effect (EC vs. Vehicle group), a mixed effect model with
repeated measures (PROC MIXED, SAS Institute Inc., Cary, NC) was applied. This model
allows inclusion of data from all time points under data missing and evaluates the treatment
effect between groups (subjects) and regions (within subject) over time; p < 0.05 is
considered to be statistically significant.
Results
1. Validation of SL-MRI by microsphere method
In order to validate SL-MRI as a method to accurately measure MBF in living animals, we
directly compared SL-MRI measurements to the standard microsphere method in 5 animals:
we cannulated the carotid and femoral arteries right before the SL-MRI session, and injected
FMs immediately after SL-MRI. MR images were first cropped and the region defined by
the blue box (Figure 1A) was processed to derive T1 maps corresponding to non-slice-
selective (T1ns, Figure 1B) and slice-selective inversion (T1ss, Figure 1C). Pixel-wise MBF
was calculated by Equation [1] (Figure 1D). MBF was also estimated by counting the
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number of FMs in myocardium (one section is shown in Figure 1E). A strong correlation
between SL-MRI and FM technique (R = 0.972) was revealed for MBF averaged from the
entire slice; a slope close to unity suggests an excellent agreement between the two
techniques (Figure 1F). To obtain regional MBF measurements, the LV wall on the MBF
map and corresponding micrographs was divided into septal, lateral, anterior and posterior
quadrants. The anterior and posterior quadrants were combined into one segment since they
were not distinguishable on tissue sections. Averaged MBF in the septal, lateral and
combined anterior/posterior segments obtained by the two methods remain well-correlated
with R value of 0.753 (Figure 1G). A good agreement between the two methods was also
demonstrated by the ICC derived from slice-averaged MBF (Table 1) and by Bland-Altman
plot (Figure 1H): it revealed a bias of −0.065 mL/min/g, which is not statistically significant
from zero (p = 0.897), with 95% limits of agreements including all but one data points. To
facilitate correlation studies, the percentage of isoflurane applied to individual animals was
varied from 1% to 2.5%, since MBF is shown to be regulated by levels of anesthesia.13 For
each animal, however, the percent isoflurane was kept the same. The heart and respiration
rate were stably maintained during the experiments (Table 2).
2. Changes in regional MBF in response to EC-transplantation
In order to establish the utility of SL-MRI to measure MBF in the setting of EC therapy, we
injected ECs or vehicle into the border zone of infarcted hearts and performed serial
evaluations over the ensuing 4 weeks. At 1-day post-MI, a relatively uniform infarct size
distribution in the two groups was obtained, 18 ± 4.7% in the EC (n = 12) vs. 17 ± 5.6% in
Vehicle (n = 10) group (Table 3, p = 0.553), which facilitated a fair comparison for EC-
mediated effects. At 1-day post-MI shown in the inset of Figure 2A, regional MBF was
depressed in the infarcted vs. remote region. In comparison of slice-averaged MBF over time
in EC vs. Vehicle group, the MBF is significantly higher in EC group at 2-weeks (p =
0.0380). A significant treatment effect on regional MBF was revealed at 2-weeks across
regions (p = 0.0057) and in the remote region across time points (p = 0.0402). When the
analysis was refined to specific region or time point, a significant treatment effect in the
infarcted region at 2-weeks (p = 0.0086) and in the remote region at 4-weeks (p = 0.0277)
were obtained. Representative MBF maps at 2-weeks indeed show higher MBF in the
infarcted segment in the EC- treated heart, which had similar infarct size as the Vehicle-
treated one (Figure 2B–E). More capillaries in the infarcted region in EC-treated hearts were
revealed by vWF immunostaining (Figure 2F–G); quantitative analysis confirmed a
significantly higher MVD in the infarcted region (p = 0.0105 EC vs. Vehicle group, Figure
2J). Furthermore, double staining for vWF and human CD34 demonstrated incorporation of
ECs into capillaries in the infarcted (Figure 2H) and border region (Figure 2I). Taken
together, these data provide convincing evidence that EC engraftment enhanced new vessel
formation, leading to improved perfusion in the infarcted region detected by SL-MRI.
At 4-weeks post-MI, while MBF in the infarcted region was no longer different between the
two groups, an elevated MBF in the remote region was detected in EC-treated hearts as
visualized in MBF maps from individual rats (Figure 3A–D) and confirmed by statistical
analysis (p = 0.0277, Figure 3E). Interestingly, elevated MBF was matched by a significant
increase (greater absolute values) in circumferential strains (Ecc) in the remote region (p =
0.0075) as well as Ecc averaged over the entire slice (p = 0.0123, Figure 3G). The enhanced
MBF and Ecc, however, did not lead to an increase in LVEF in EC group (Table 3),
suggesting that LVEF is not sensitive to detect local changes in perfusion and wall motion.
While MVD was greater in all regions of EC-treated hearts, statistical significance was not
obtained in any region (Figure 3F). Compared to 1-day post-MI, infarct size decreased in
both EC and Vehicle groups (Table 3), likely due to wall thinning in the infarcted region
observed frequently in both groups. Compared to 2-weeks post-MI, CD34 positive cells
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were rarely found in sections (data not shown) suggesting the vast majority of transplanted
cells were dead or removed.
Finally, the SL-MRI method is shown to have a high degree of reproducibility by ICC
(Table 1) and by the Bland-Altman plot of regional MBF, which revealed a uniform
distribution of differences in MBF (scan2-scan1) around a bias very close to zero (Figure 4).
For reproducibility as well as validation study, segment-specific ICC values are relatively
low in one or two segments, suggesting a decreased agreement in these segments.
Discussion
HUVECs are commercially available and can be expanded to a large number in vitro,
therefore providing a convenient EC source for this proof-of-principle study to examine
whether or not SL-MRI is able to detect temporal changes of regional MBF in response to
EC engraftment in the infarcted heart. Our results suggest that EC transplantation induces a
strong neovascularization response in the infarcted region detectable at 2-weeks post
injection, leading to a substantial increase of regional blood flow and capillary density
accompanied by incorporation of grafted ECs into capillaries in the infarcted and border
regions (Figure 2). The localized responses, although strong, appear to be short-termed and
transit to a prominent increase of MBF in the remote territory (Figure 3E). This finding is
intriguing because it is generally expected that only infarcted and border zones would
benefit from EC engraftment. However, there is compelling evidence that the remote region
is affected during unfavorable post-MI remodeling 28 and stem cells may partially rescue/
stabilize that region 29. Consistently, an increase in MBF was accompanied by a recovery of
wall motion (Ecc) in the remote region.
SL-MRI (also called arterial spin labeling) has achieved a great success in measuring blood
flow in the brain 30. In conventional brain SL, the RF inversion pulse is typically introduced
at an upstream location proximal to the tissue of interest. For MBF measurement, however,
on-slice SL, namely, flow-sensitive alternating inversion recovery (FAIR)31 technique, can
minimize the magnetization transfer artifact and the underestimation of flow when feeding
arteries have tortuous paths. SL-based MBF in small rodents is based on T1 mapping and
the arterial transit time (ATT) is ignored. This approach might be justified by the fact that
small rodents have much higher MBF (3–5 mL/min/g 11,20,32) than humans (0.7–1 mL/
min/g 33) and are studied at higher field strength than clinical scanners, leading to prolonged
blood T1. Therefore, the ATT of un-inverted blood spins is much shorter than blood T1,
which allows a measurable inflow effect in slice-selective T1 values 12. ATT of human heart
was estimated at 1.5T recently34. While further study is necessary to evaluate the effect of
ATT on MBF quantification in small rodents, our validation study suggests the T1 mapping
approach is in excellent agreement with standard microsphere method.
While the goals of this study have been fulfilled, several limitations should be discussed.
First, compared to the resting MBF, coronary flow reserve, CFR, might be more
representative of coronary microvascular function than the resting MBF 35. CFR
measurement can be implemented via pharmacological stimulation in SL-MRI protocol for
future studies. Second, single slice MBF was obtained in the current protocol due to
relatively lengthy acquisition time (≥ 25 min), which could lead to concerns that MBF may
vary during acquisition. Inversion recovery based T1 mapping, while being the most robust
method, is inherently time-consuming. Non-Cartesian k-space trajectory such as spiral 16 or
radial 36 imaging techniques can reduce acquisition time and resist respiratory motion.
Third, due to inflammatory reactions induced by acute MI and/or the use of human cells in a
rat model (albeit immune-compromised), injection of ECs during MI surgery might have a
negative impact on EC survival. Therefore, better EC engraftment is expected if they are
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injected 7 days post-MI as we have shown with embryonic stem cell derived
cardiomyocytes.19 Finally, the high post-surgery mortality rate and the exclusion of 7 rats
from the Aim-2 analysis because of unqualified infarct size raise the possibility of selection
bias in addition to impacting statistical power.
In summary, our results indicate excellent agreement of MBF in free-breathing rats
measured by SL-MRI and the standard color microsphere technique. Non-invasive SL-MRI
allows serial assessments of regional MBF in response to EC treatment. The presented
method offers a promising framework to quantify MBF as a specific and sensitive index to
evaluate EC-mediated therapy for the infarcted heart.
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Figure 1. (A–H): Validation of SL-MRI based MBF with color microsphere technique
Non-slice selective T1 map (T1ns, B), slice selective T1 map (T1ss, C) and MBF map (D)
calculated from the area enclosed in the blue box on the corresponding GRE image (A).
White arrows point to the reference phantom while yellow arrows point to the catheter
inside the LV. Distribution of FMs in a section (E). Correlation of MBF measured by SL-
MRI vs. FM technique: average from entire slice (F) or segments (G). Myocardium wall on
MBF maps and on micrographs of tissue sections was divided into 3 segments (septal,
lateral, and combined anterior/posterior), resulting in 3 data points per animal × 5 animals =
15 points in G. For Bland-Altman analysis (H), the difference of MBF, (SL − FM), was
plotted against the average of MBF, (SL+ FM)/2; mean difference (bias) and the 95% limits
of agreement defined as bias ± 1.96 standard deviation (STD= 0.767 mL/min/g) were
computed.
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Figure 2. (A–J): Regional MBF estimated by in vivo MRI and MVD at 2-weeks post-MI
Slice-average and regional MBF at 1-day (inset of A) and 2-weeks post-MI (A). The MBF
maps and corresponding LGE images were shown for a representative heart from EC (B–C,
arrows pointing to the phantom) and Vehicle group (D–E). Immunostaining for vWF from
an EC- (F) or Vehicle-treated heart (G). Double immunostaining of CD34 which reacts only
to human tissue and vWF antibody which reacts to rat and human antigen revealed
incorporation of ECs into capillaries in the infarcted (H) and border (I) region. Scale bars =
100 μm. MVD (= the number of capillaries per field of 1.1 mm2). *: statistically significant
comparing the EC vs. Vehicle group (A, J).
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Figure 3. (A–G): Regional MBF and wall motion estimated by MRI and MVD at 4-weeks post-
MI
MBF maps and corresponding LGE images were shown for a representative heart from the
EC (A–B) and Vehicle group (C–D). Regional MBF (E), MVD (F) and Ecc (G) from the EC
and Vehicle group. *: statistically significant comparing the EC vs. Vehicle group (E, G).
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Figure 4. Blandt-Altman plot demonstrating the test-retest reproducibility of SL-MRI method
Average MBF was obtained from the septal, anterior, posterior and lateral segment for each
animal. The bias between the retest and test scan is 0.088 mL/min/g with STD = 0.533 mL/
min/g.
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Table 2
Cardiac and respiratory period of the animals during the validation study.
Animal Cardiac Cycle (ms) Respiratory Cycle (ms)
1 212 ± 15 1083 ± 169
2 210 ± 9 1071 ± 128
3 160 ± 14 723 ± 47
4 170 ± 7 1414 ± 50
5 178 ± 2 1101 ± 62
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Table 3
Infarct size and global function estimated by MRI at 1 day and 4 weeks post-MI
Day 1 Week 4
Infarct sizea LVEFb Infarct sizea LVEFb
EC 18.3±4.7% 57.3±6.9% 4.3±2.6% 59.2±9.0%
Vehicle 16.8±5.6% 55.6±4.8% 6.2±2.6% 59.4±6.9%
a, b
No statistical significance was observed between the two study groups (p > 0.1).
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